Stay updated on Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page.

Latest updates to the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no changes to study content or functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedMinor site version update from v3.4.0 to v3.4.1 with no impact on study data, content, or usability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedUpdate from v3.3.3 to v3.3.4 appears to be an internal revision with no visible changes to study details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a comprehensive Locations section listing sites by state (AL, AZ, AR, CA, CO, FL, GA, MA, NV, NM, NY, OH, PA, TN, TX). Replaced the old per-state location headings and updated the revision to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; there are no visible changes to study details, eligibility, or other user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check99 days agoChange DetectedThe bottom notice about funding and NIH operating status was removed; this does not affect core study details, eligibility criteria, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page.